Medical research

Excitotoxicity and nerve cell death

Neural excitotoxicity can be involved in spinal cord injury, traumatic hearing loss and Alzheimer's. The Stressprotect project has gathered data on this often devastating phenomenon at biochemical, genomic and physiological ...

Medications

Tafamidis: Approval denotes proven added benefit

Tafamidis meglumine (trade name: Vyndaqel) was approved in November 2011 for the treatment of transthyretin amyloidosis in adults. This rare disorder ("orphan disease") is caused by a defective gene and is associated with ...

Diseases, Conditions, Syndromes

Thermal sensation spared in nerve-sparing prostatectomy

(HealthDay)—Penile thermal sensory thresholds increase after non-nerve-sparing radical prostatectomy (RP) but not after the nerve-sparing procedure, according to a study published in the September issue of The Journal of ...

Oncology & Cancer

Marqibo approved for rare leukemia

(HealthDay) -- Marqibo (vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with a rare form of blood and bone marrow cancer, Philadelphia chromosome negative ...

Medications

Marqibo approved for ph- acute lymphoblastic leukemia

(HealthDay) -- Marqibo (vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with Philadelphia chromosome negative acute lymphoblastic leukemia (ALL).

Immunology

Sea anemones venom key to Multiple Sclerosis treatment

(Medical Xpress) -- Sea anemones use venomous stinging tentacles to stun their prey, but one component of that venom is being used by researchers to treat the debilitating effects of Multiple Sclerosis (MS).

page 21 from 25